Found: 75
Select item for more details and to access through your institution.
Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2014, v. 30, n. 8, p. 693, doi. 10.1002/dmrr.2537
- By:
- Publication type:
- Article
Efficacy of alogliptin, a dipeptidyl peptidase-4 inhibitor, on glucose parameters, the activity of the advanced glycation end product (AGE) - receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetes.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2013, v. 29, n. 8, p. 624, doi. 10.1002/dmrr.2437
- By:
- Publication type:
- Article
Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2013, v. 29, n. 5, p. 406, doi. 10.1002/dmrr.2407
- By:
- Publication type:
- Article
Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).
- Published in:
- Diabetes/Metabolism Research & Reviews, 2009, v. 25, n. 3, p. 266, doi. 10.1002/dmrr.906
- By:
- Publication type:
- Article
Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2008, v. 24, n. 2, p. 109, doi. 10.1002/dmrr.766
- By:
- Publication type:
- Article
Involvement of Toxic AGEs (TAGE) in the Pathogenesis of Diabetic Vascular Complications and Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 16, n. 4, p. 845, doi. 10.3233/JAD-2009-0974
- By:
- Publication type:
- Article
Pyridoxamine and Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-Products.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.921611
- By:
- Publication type:
- Article
Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.
- Published in:
- Journal of Gastroenterology, 2010, v. 45, n. 7, p. 750, doi. 10.1007/s00535-010-0203-y
- By:
- Publication type:
- Article
The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.
- Published in:
- Journal of Gastroenterology, 2010, v. 45, n. 6, p. 646, doi. 10.1007/s00535-009-0193-9
- By:
- Publication type:
- Article
Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells.
- Published in:
- Journal of Gastroenterology, 2008, v. 43, n. 4, p. 298, doi. 10.1007/s00535-007-2152-7
- By:
- Publication type:
- Article
Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 14, p. 4861, doi. 10.3390/ijms21144861
- By:
- Publication type:
- Article
Vardenafil, an inhibitor of phosphodiesterase-5, blocks advanced glycation end product (AGE)-induced up-regulation of monocyte chemoattractant protein-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression via elevation of cGMP.
- Published in:
- Clinical & Experimental Medicine, 2011, v. 11, n. 2, p. 131, doi. 10.1007/s10238-010-0109-2
- By:
- Publication type:
- Article
An α-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Intracellular Toxic Advanced Glycation End-Products May Induce Cell Death and Suppress Cardiac Fibroblasts.
- Published in:
- Metabolites (2218-1989), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/metabo12070615
- By:
- Publication type:
- Article
Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.
- Published in:
- Journal of Ophthalmology, 2010, p. 1, doi. 10.1155/2010/170393
- By:
- Publication type:
- Article
Glyceraldehyde caused Alzheimer's disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells.
- Published in:
- Scientific Reports, 2015, p. 13313, doi. 10.1038/srep13313
- By:
- Publication type:
- Article
Assessment of the Concentrations of Various Advanced Glycation End-Products in Beverages and Foods That Are Commonly Consumed in Japan.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0118652
- By:
- Publication type:
- Article
Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0070034
- By:
- Publication type:
- Article
Proteasome inhibition induces selective motor neuron death in organotypic slice cultures.
- Published in:
- Journal of Neuroscience Research, 2005, v. 82, n. 4, p. 443, doi. 10.1002/jnr.20665
- By:
- Publication type:
- Article
Receptor for Advanced Glycation End Products Is a Promising Target of Diabetic Nephropathy.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1043, n. 1, p. 562, doi. 10.1196/annals.1333.064
- By:
- Publication type:
- Article
Structures of Toxic Advanced Glycation End-Products Derived from Glyceraldehyde, A Sugar Metabolite.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 2, p. 202, doi. 10.3390/biom14020202
- By:
- Publication type:
- Article
Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 3, p. 387, doi. 10.3390/biom11030387
- By:
- Publication type:
- Article
Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice.
- Published in:
- Genes to Cells, 2008, v. 13, n. 11, p. 1159, doi. 10.1111/j.1365-2443.2008.01234.x
- By:
- Publication type:
- Article
Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report.
- Published in:
- Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 3, doi. 10.1186/1475-2840-13-15
- By:
- Publication type:
- Article
Relationship between Advanced Glycation End Products and Plaque Progression in Patients with Acute Coronary Syndrome: The JAPAN-ACS Sub-study.
- Published in:
- Cardiovascular Diabetology, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1475-2840-12-5
- By:
- Publication type:
- Article
Immunological evidence for in vivo production of novel advanced glycation end-products from 1,5-anhydro-D-fructose, a glycogen metabolite.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-46333-2
- By:
- Publication type:
- Article
Effects of high-AGE beverage on RAGE and VEGF expressions in the liver and kidneys.
- Published in:
- European Journal of Nutrition, 2009, v. 48, n. 1, p. 6, doi. 10.1007/s00394-008-0753-4
- By:
- Publication type:
- Article
Prediagnostic serum glyceraldehyde‐derived advanced glycation end products and mortality among colorectal cancer patients.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 11, p. 2257, doi. 10.1002/ijc.34449
- By:
- Publication type:
- Article
Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction.
- Published in:
- Diabetes & Vascular Disease Research, 2013, v. 10, n. 5, p. 436, doi. 10.1177/1479164113486662
- By:
- Publication type:
- Article
Glyceraldehyde-derived advanced glycation end products in Alzheimer’s disease.
- Published in:
- Acta Neuropathologica, 2004, v. 108, n. 3, p. 189, doi. 10.1007/s00401-004-0871-x
- By:
- Publication type:
- Article
Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis.
- Published in:
- Diabetology & Metabolic Syndrome, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13098-021-00685-w
- By:
- Publication type:
- Article
Toxic AGEs (TAGE) theory: a new concept for preventing the development of diseases related to lifestyle.
- Published in:
- Diabetology & Metabolic Syndrome, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13098-020-00614-3
- By:
- Publication type:
- Article
Regulation of Human Melanoma Growth and Metastasis by AGE–AGE Receptor Interactions.
- Published in:
- Journal of Investigative Dermatology, 2004, v. 122, n. 2, p. 461, doi. 10.1046/j.0022-202X.2004.22218.x
- By:
- Publication type:
- Article
Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin.
- Published in:
- FASEB Journal, 2002, v. 16, n. 14, p. 1928, doi. 10.1096/fj.02-0030fje
- By:
- Publication type:
- Article
Toxic Advanced Glycation End Products (TAGE) Theory in Alzheimer's Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2006, v. 21, n. 3, p. 197, doi. 10.1177/1533317506289277
- By:
- Publication type:
- Article
Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non-B or Non-C Hepatocellular Carcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Advanced glycation end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Involvement of Intracellular TAGE and the TAGE–RAGE–ROS Axis in the Onset and Progression of NAFLD/NASH.
- Published in:
- Antioxidants, 2023, v. 12, n. 3, p. 748, doi. 10.3390/antiox12030748
- By:
- Publication type:
- Article
Calcium Channel Blocker Inhibition of AGE and RAGE Axis Limits Renal Injury in Nondiabetic Patients With Stage I or II Chronic Kidney Disease.
- Published in:
- Clinical Cardiology, 2011, v. 34, n. 6, p. 372, doi. 10.1002/clc.20885
- By:
- Publication type:
- Article
Low-Density Lipoprotein Levels are One of the Independent Determinants of Circulating Levels of Advanced Glycation End Products in Nondiabetic Subjects.
- Published in:
- Clinical Cardiology, 2009, v. 32, n. 9, p. E12, doi. 10.1002/clc.20532
- By:
- Publication type:
- Article
RasGRP2 inhibits glyceraldehyde-derived toxic advanced glycation end-products from inducing permeability in vascular endothelial cells.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82619-0
- By:
- Publication type:
- Article
Neuropathy induced by exogenously administered advanced glycation end-products in rats.
- Published in:
- Journal of Diabetes Investigation, 2010, v. 1, n. 1/2, p. 40, doi. 10.1111/j.2040-1124.2009.00002.x
- By:
- Publication type:
- Article
Advanced glycation end products impair glucose-induced insulin secretion from rat pancreatic β-cells.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2014, v. 21, n. 2, p. 134, doi. 10.1002/jhbp.12
- By:
- Publication type:
- Article
RAGE Control of Diabetic Nephropathy in a Mouse Model.
- Published in:
- Diabetes, 2006, v. 55, n. 9, p. 2510, doi. 10.2337/db06-0221
- By:
- Publication type:
- Article
Receptor for Advanced Glycation End Products Is Involved in Impaired Angiogenic Response in Diabetes.
- Published in:
- Diabetes, 2006, v. 55, n. 8, p. 2245, doi. 10.2337/db05-1375
- By:
- Publication type:
- Article
Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases.
- Published in:
- Diagnostics (2075-4418), 2016, v. 6, n. 2, p. 23, doi. 10.3390/diagnostics6020023
- By:
- Publication type:
- Article
A Novel Approach: Investigating the Intracellular Clearance Mechanism of Glyceraldehyde-Derived Advanced Glycation End-Products Using the Artificial Checkpoint Kinase 1 d270KD Mutant as a Substrate Model.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 24, p. 2838, doi. 10.3390/cells12242838
- By:
- Publication type:
- Article
Effects of Toxic AGEs (TAGE) on Human Health.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 14, p. N.PAG, doi. 10.3390/cells11142178
- By:
- Publication type:
- Article
Atorvastatin reduces proteinuria in non-diabetic chronic kidney disease patients partly via lowering serum levels of advanced glycation end products (AGEs).
- Published in:
- Oxidative Medicine & Cellular Longevity, 2010, v. 3, n. 5, p. 304, doi. 10.4161/oxim.3.5.13069
- By:
- Publication type:
- Article
Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2010, v. 3, n. 4, p. 262, doi. 10.4161/oxim.3.4.12734
- By:
- Publication type:
- Article